Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback